Ignite Creation Date:
2025-12-24 @ 6:26 PM
Ignite Modification Date:
2026-01-05 @ 5:39 PM
Study NCT ID:
NCT04684368
Status:
RECRUITING
Last Update Posted:
2025-12-22
First Post:
2020-12-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D002822', 'term': 'Choriocarcinoma'}, {'id': 'D018236', 'term': 'Carcinoma, Embryonal'}, {'id': 'D013724', 'term': 'Teratoma'}], 'ancestors': [{'id': 'D014328', 'term': 'Trophoblastic Neoplasms'}, {'id': 'D009373', 'term': 'Neoplasms, Germ Cell and Embryonal'}, {'id': 'D009370', 'term': 'Neoplasms by Histologic Type'}, {'id': 'D009369', 'term': 'Neoplasms'}, {'id': 'D000230', 'term': 'Adenocarcinoma'}, {'id': 'D002277', 'term': 'Carcinoma'}, {'id': 'D009375', 'term': 'Neoplasms, Glandular and Epithelial'}, {'id': 'D011252', 'term': 'Pregnancy Complications, Neoplastic'}, {'id': 'D011248', 'term': 'Pregnancy Complications'}, {'id': 'D005261', 'term': 'Female Urogenital Diseases and Pregnancy Complications'}, {'id': 'D000091642', 'term': 'Urogenital Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D013048', 'term': 'Specimen Handling'}, {'id': 'D016190', 'term': 'Carboplatin'}, {'id': 'D005047', 'term': 'Etoposide'}, {'id': 'D000069585', 'term': 'Filgrastim'}, {'id': 'D016179', 'term': 'Granulocyte Colony-Stimulating Factor'}, {'id': 'D007069', 'term': 'Ifosfamide'}, {'id': 'D009682', 'term': 'Magnetic Resonance Spectroscopy'}, {'id': 'D015080', 'term': 'Mesna'}, {'id': 'C455861', 'term': 'pegfilgrastim'}, {'id': 'C423652', 'term': 'pegylated granulocyte colony-stimulating factor'}, {'id': 'D036102', 'term': 'Peripheral Blood Stem Cell Transplantation'}, {'id': 'D011878', 'term': 'Radiotherapy'}, {'id': 'D011827', 'term': 'Radiation'}, {'id': 'D024162', 'term': 'Second-Look Surgery'}, {'id': 'D012086', 'term': 'Reoperation'}, {'id': 'D013852', 'term': 'Thiotepa'}], 'ancestors': [{'id': 'D019411', 'term': 'Clinical Laboratory Techniques'}, {'id': 'D019937', 'term': 'Diagnostic Techniques and Procedures'}, {'id': 'D003933', 'term': 'Diagnosis'}, {'id': 'D008919', 'term': 'Investigative Techniques'}, {'id': 'D056831', 'term': 'Coordination Complexes'}, {'id': 'D009930', 'term': 'Organic Chemicals'}, {'id': 'D011034', 'term': 'Podophyllotoxin'}, {'id': 'D013764', 'term': 'Tetrahydronaphthalenes'}, {'id': 'D009281', 'term': 'Naphthalenes'}, {'id': 'D011084', 'term': 'Polycyclic Aromatic Hydrocarbons'}, {'id': 'D006841', 'term': 'Hydrocarbons, Aromatic'}, {'id': 'D006844', 'term': 'Hydrocarbons, Cyclic'}, {'id': 'D006838', 'term': 'Hydrocarbons'}, {'id': 'D011083', 'term': 'Polycyclic Compounds'}, {'id': 'D005960', 'term': 'Glucosides'}, {'id': 'D006027', 'term': 'Glycosides'}, {'id': 'D002241', 'term': 'Carbohydrates'}, {'id': 'D003115', 'term': 'Colony-Stimulating Factors'}, {'id': 'D006023', 'term': 'Glycoproteins'}, {'id': 'D006001', 'term': 'Glycoconjugates'}, {'id': 'D016298', 'term': 'Hematopoietic Cell Growth Factors'}, {'id': 'D016207', 'term': 'Cytokines'}, {'id': 'D036341', 'term': 'Intercellular Signaling Peptides and Proteins'}, {'id': 'D010455', 'term': 'Peptides'}, {'id': 'D000602', 'term': 'Amino Acids, Peptides, and Proteins'}, {'id': 'D011506', 'term': 'Proteins'}, {'id': 'D001685', 'term': 'Biological Factors'}, {'id': 'D003520', 'term': 'Cyclophosphamide'}, {'id': 'D010752', 'term': 'Phosphoramide Mustards'}, {'id': 'D009588', 'term': 'Nitrogen Mustard Compounds'}, {'id': 'D009150', 'term': 'Mustard Compounds'}, {'id': 'D006846', 'term': 'Hydrocarbons, Halogenated'}, {'id': 'D063088', 'term': 'Phosphoramides'}, {'id': 'D009943', 'term': 'Organophosphorus Compounds'}, {'id': 'D010078', 'term': 'Oxazines'}, {'id': 'D006573', 'term': 'Heterocyclic Compounds, 1-Ring'}, {'id': 'D006571', 'term': 'Heterocyclic Compounds'}, {'id': 'D013057', 'term': 'Spectrum Analysis'}, {'id': 'D002623', 'term': 'Chemistry Techniques, Analytical'}, {'id': 'D000476', 'term': 'Alkanesulfonates'}, {'id': 'D017738', 'term': 'Alkanesulfonic Acids'}, {'id': 'D000473', 'term': 'Alkanes'}, {'id': 'D006839', 'term': 'Hydrocarbons, Acyclic'}, {'id': 'D013438', 'term': 'Sulfhydryl Compounds'}, {'id': 'D013457', 'term': 'Sulfur Compounds'}, {'id': 'D013451', 'term': 'Sulfonic Acids'}, {'id': 'D013456', 'term': 'Sulfur Acids'}, {'id': 'D018380', 'term': 'Hematopoietic Stem Cell Transplantation'}, {'id': 'D033581', 'term': 'Stem Cell Transplantation'}, {'id': 'D017690', 'term': 'Cell Transplantation'}, {'id': 'D064987', 'term': 'Cell- and Tissue-Based Therapy'}, {'id': 'D001691', 'term': 'Biological Therapy'}, {'id': 'D013812', 'term': 'Therapeutics'}, {'id': 'D014180', 'term': 'Transplantation'}, {'id': 'D013514', 'term': 'Surgical Procedures, Operative'}, {'id': 'D055585', 'term': 'Physical Phenomena'}, {'id': 'D013721', 'term': 'Triethylenephosphoramide'}, {'id': 'D001388', 'term': 'Aziridines'}, {'id': 'D001389', 'term': 'Azirines'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE2'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NON_RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 160}}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2021-07-13', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-08', 'completionDateStruct': {'date': '2029-12-21', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2025-12-18', 'studyFirstSubmitDate': '2020-12-15', 'studyFirstSubmitQcDate': '2020-12-22', 'lastUpdatePostDateStruct': {'date': '2025-12-22', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2020-12-24', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2029-12-21', 'type': 'ESTIMATED'}}, 'outcomesModule': {'otherOutcomes': [{'measure': 'Change in intelligence scores within each treatment arm', 'timeFrame': 'Baseline up to 60 months post-treatment initiation', 'description': "Will be assessed by the Wechsler Preschool and Primary Scale of Intelligence 4th Edition (WPPSI-IV), Wechsler Intelligence Scale for Children 5th Edition (WISC-V), and the Wechsler Adult Intelligence Scale 4th Edition (WAIS-IV), depending on patient's age. One-sample confidence intervals will be used to estimate mean pairwise changes in intelligence scores between 2 time points within each treatment arm."}, {'measure': 'Change in intelligence scores between treatment arms', 'timeFrame': 'Baseline up to 60 months post-treatment initiation', 'description': "Will be assessed by the Wechsler Preschool and Primary Scale of Intelligence 4th Edition (WPPSI- IV), Wechsler Intelligence Scale for Children 5th Edition (WISC V), and the Wechsler Adult Intelligence Scale 4th Edition (WAIS-IV), depending on patient's age. A 2-sample confidence interval approach will be used to estimate the difference in score changes between the two cohorts (WVSCI versus HDCSCR) in order to describe differential effects of the 2 treatment strategies."}, {'measure': 'Change in processing speed/attention within each treatment arm', 'timeFrame': 'Baseline up to 60 months post-treatment initiation', 'description': 'Will be assessed by the WISC-V or WAIS-IV processing speed index tasks. One-sample confidence intervals will be used to estimate mean pairwise changes in scores between 2 time points within each treatment arm.'}, {'measure': 'Change in processing speed/attention between the two treatment arms', 'timeFrame': 'Baseline up to 60 months post-treatment initiation', 'description': 'Will be assessed by the WISC-V or WAIS-IV processing speed index tasks. A 2-sample confidence interval approach will be used to estimate the difference in score changes between the two cohorts (WVSCI versus HDCSCR) in order to describe differential effects of the 2 treatment strategies.'}, {'measure': 'Change in immediate visual memory within each arm', 'timeFrame': 'Baseline up to 60 months post-treatment initiation', 'description': "Will be assessed by the Children's Memory Scale and California Verbal Learning Test. One-sample confidence intervals will be used to estimate mean pairwise changes in scores between 2 time points within treatment arms, as appropriate."}, {'measure': 'Change in social-emotional functioning within each arm', 'timeFrame': 'Baseline up to 60 months post-treatment initiation', 'description': 'Will be assessed by the Behavior Assessment System for Children - 3rd Edition. One-sample confidence intervals will be used to estimate mean pairwise changes in scores between 2 time points within treatment arms, as appropriate.'}, {'measure': 'Change in adaptive functioning within each arm', 'timeFrame': 'Baseline up to 60 months post-treatment initiation', 'description': 'Will be assessed by the Adaptive Behavior Assessment System - 3rd Edition. One-sample confidence intervals will be used to estimate mean pairwise changes in scores between 2 time points within treatment arms, as appropriate.'}, {'measure': 'Change in health-related quality of life within each arm', 'timeFrame': 'Baseline up to 60 months post-treatment initiation', 'description': 'Will be assessed by the Pediatric Quality of Life Inventory version 4.0. One-sample confidence intervals will be used to estimate mean pairwise changes in scores between 2 time points within treatment arms, as appropriate.'}, {'measure': 'Change in health-related quality of life between the two treatment arms', 'timeFrame': 'Baseline up to 60 months post-treatment initiation', 'description': 'Will be assessed by the Pediatric Quality of Life Inventory version 4.0. 2-sample confidence interval approach will be used to estimate the difference in score changes between the two cohorts (WVSCI versus HDCSCR) in order to describe differential effects of the 2 treatment strategies.'}, {'measure': 'Radiation modality (proton versus photon)', 'timeFrame': 'Up to 10 years', 'description': 'Will summarize and compare functional outcomes, including cognitive, social and behavioral functioning, and auditory and neuro-endocrine function, in the context of the radiation therapy modality used. Two sample t-tests for specified timepoints within each of the two treatment cohorts (WVSCI versus HDCSCR) will be used for comparisons.'}, {'measure': 'Growth comparisons following radiation by radiation modality', 'timeFrame': 'Up to 10 years', 'description': 'Will compare early and late outcomes for proton and photon therapy with and without vertebral body sparing. Height and weight of subjects who are \\< 13 years at the time of radiation therapy will be collected until subjects go off study or reach the age of 21, whichever is earlier. Percentile values standardizing height and weight based on appropriate growth curves will be used to compare cohorts treated with proton- versus photon-based radiation therapy.'}, {'measure': 'Complete blood count values following radiation by radiation modality', 'timeFrame': 'Up to 1 year post treatment initiation', 'description': 'Complete blood count values during radiation therapy will be used to compare these outcomes in the context of proton- versus photon-based radiation therapy.'}, {'measure': 'Local versus central review recommendations for second-look surgery', 'timeFrame': 'Up to 1 year post treatment initiation', 'description': 'Will summarize the local versus central review recommendations for second-look surgery and document any discrepancies.'}], 'primaryOutcomes': [{'measure': 'Failure rate', 'timeFrame': 'Within 2 years of enrollment', 'description': 'Will be measured by the number of progressions or deaths within 2 years of enrollment for the cohort treated with whole ventricular + spinal canal irradiation (WVSCI). The final analysis will include an exact binomial confidence interval of the failure rate for each of the failure types (local, distant/spinal or both) without adjustment for multiplicity.'}, {'measure': 'Spinal failure rate', 'timeFrame': 'Within 2 years of enrollment', 'description': 'Will be measured by the number of spinal relapses (spine alone or distant relapses including the spine) within 2 years of enrollment in patients treated with WVSCI. The final analysis will include an exact binomial confidence interval of spinal failure rate.'}], 'secondaryOutcomes': [{'measure': 'Radiographic complete response (CR)/partial response (PR) with marker normalization rate post induction/second-look surgery', 'timeFrame': 'Approximately 6 to 9 months post-treatment initiation', 'description': 'Will be assessed in patients treated with induction chemotherapy. Will be estimated using an exact binomial approach and its confidence interval.'}, {'measure': 'Radiographic complete response (CR)/partial response (PR) with marker normalization rate post high-dose chemotherapy with peripheral stem cell rescue (HDCSCR)', 'timeFrame': 'Up to 2 years post-treatment initiation', 'description': 'Will be assessed in patients treated with HDCSCR. Will be estimated using an exact binomial approach and its confidence interval.'}, {'measure': 'Progression-free survival (PFS)', 'timeFrame': 'From enrollment until disease progression or death from any cause for patients with events, and until final follow up for those who are event free at the time of analysis, assessed up to 10 years', 'description': 'Will be estimated separately for those treated with WVSCI and with HDCSCR + radiation therapy. Kaplan-Maier based PFS curve estimates will be included, where patients who are lost to follow up will be treated as censored observations as part of the primary analyses.'}, {'measure': 'Overall survival (OS)', 'timeFrame': 'From enrollment until death from any cause for patients with events and until final follow up for those who are alive at the time of analysis, assessed up to 10 years', 'description': 'Will be estimated separately for those treated with WVSCI and with HDCSCR + radiation therapy. Kaplan-Maier based OS curve estimates will be included, where patients who are lost to follow up will be treated as censored observations as part of the secondary analyses.'}, {'measure': 'Patterns of disease recurrence/failure', 'timeFrame': 'Up to 10 years', 'description': 'Will be analyzed in an exploratory manner with respect to radiation dose distribution.'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': True, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Central Nervous System Nongerminomatous Germ Cell Tumor', 'Choriocarcinoma', 'Embryonal Carcinoma', 'Immature Teratoma', 'Malignant Teratoma', 'Mixed Germ Cell Tumor', 'Pineal Region Germ Cell Tumor', 'Pineal Region Immature Teratoma', 'Pineal Region Yolk Sac Tumor', 'Suprasellar Germ Cell Tumor']}, 'descriptionModule': {'briefSummary': "This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other parts of the brain or body (localized). This study has 2 goals: 1) optimizing radiation for patients who respond well to induction chemotherapy to diminish spinal cord relapses, 2) utilizing higher dose chemotherapy followed by conventional RT in patients who did not respond to induction chemotherapy. Chemotherapy drugs, such as carboplatin, etoposide, ifosfamide, and thiotepa, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays or high-energy protons to kill tumor cells and shrink tumors. Studies have shown that patients with newly-diagnosed localized NGGCT, whose disease responds well to chemotherapy before receiving radiation therapy, are more likely to be free of the disease for a longer time than are patients for whom the chemotherapy does not efficiently eliminate or reduce the size of the tumor. The purpose of this study is to see how well the tumors respond to induction chemotherapy to decide what treatment to give next. Some patients will be given RT to the spine and a portion of the brain. Others will be given high dose chemotherapy and a stem cell transplant before RT to the whole brain and spine. Giving treatment based on the response to induction chemotherapy may lower the side effects of radiation in some patients and adjust the therapy to a more efficient one for other patients with localized NGGCT.", 'detailedDescription': "PRIMARY OBJECTIVES:\n\nI. To monitor outcome to ensure that children and young adults with localized central nervous system (CNS) non-germinomatous germ cell tumors (NGGCT) treated with induction chemotherapy followed by response evaluation and whole ventricular + spinal canal irradiation (WVSCI) will maintain the excellent 2-year progression free survival (PFS) rate as compared to ACNS0122 (NCT00047320).\n\nII. To improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and receive WVSCI as compared to whole ventricular radiation on ACNS1123 (NCT01602666).\n\nSECONDARY OBJECTIVES:\n\nI. To estimate the response rates to induction chemotherapy and WVSCI for localized NGGCT patients who achieve a CR/PR.\n\nII. To estimate the PFS and overall survival (OS) for localized NGGCT patients who achieve a CR/PR and receive WVSCI.\n\nIII. To estimate the PFS and OS for patients with less than a CR/PR following Induction who subsequently receive high-dose chemotherapy with peripheral stem cell rescue (HDCSCR).\n\nIV. To estimate the response rate for patients with less than a CR/PR following Induction who subsequently receive HDCSCR.\n\nEXPLORATORY OBJECTIVES:\n\nI. To prospectively compare outcomes based on radiation modality, photon versus proton, including cognitive, social and behavioral functioning, auditory, and neuro-endocrine function.\n\nII. To compare spinal column growth and cell counts following radiation as measured by height and weight, and complete blood count (CBC) values during and after radiation therapy, based on treatment modality (photon versus \\[vs.\\] proton therapy) and planned inclusion/exclusion of the vertebral body in patients \\< 13 years of age.\n\nIII. To compare local vs. central review recommendations for second-look surgery and document barriers for performing such surgeries as well as their clinical benefit in pediatric NGGCT.\n\nIV. To prospectively evaluate and longitudinally model the cognitive, social, and behavioral functioning of children and young adults with localized CNS NGGCT with testing as per the Children's Oncology Group (COG) Standardized Neuropsychological and Behavioral Battery.\n\nV. To evaluate patterns of disease recurrence/failure with respect to radiation dose distribution.\n\nOUTLINE:\n\nINDUCTION CHEMOTHERAPY: Patients receive carboplatin intravenously (IV) over 15-60 minutes on day 1 and etoposide IV over 90-120 minutes on days 1-3 of cycles 1, 3, and 5. Patients also receive ifosfamide IV over 60 minutes and etoposide IV over 60-120 minutes on days 1-5 of cycles 2, 4, and 6. Treatment repeats every 21 days for up to 6 cycles in the absence of disease progression or unacceptable toxicity.\n\nPatients are assigned to 1 of 2 plans (ventricular + spinal canal irradiation \\[WVSCI\\] or high-dose chemotherapy with peripheral stem cell rescue \\[HDCSCR\\]) based on response to induction chemotherapy:\n\n* Patients who achieve radiographic CR/PR with marker normalization proceed to WVSCI. Patients who achieve radiographic CR without marker normalization proceed to HDCSCR.\n* Patients who achieve less than radiographic CR/PR with marker normalization proceed to second-look surgery (unless contraindicated). If second-look surgery reveals mature teratoma or non-viable tumor, proceed to WVSCI. If second-look surgery reveals viable tumor, proceed to HDCSCR. Patients who are unable to undergo second-look surgery are removed from protocol therapy but remain on study for follow-up.\n* Patients who achieve less than radiographic CR/PR without marker normalization proceed to second-look surgery (unless contraindicated). Patients then proceed to HDCSCR regardless of whether or not a second-look surgery is performed.\n* Patients who achieve radiographic PR without marker normalization proceed to second-look surgery (unless contraindicated). Patients then proceed to HDCSCR regardless of whether or not a second-look surgery is performed.\n\nPLAN A (WVSCI THERAPY): Within 6 weeks of the end of induction chemotherapy or second-look surgery, patients undergo WVSCI once daily (QD) for 5 days weekly (17 fractions followed by a boost dose for 13 fractions) for 6 weeks in the absence of disease progression or unacceptable toxicity.\n\nPLAN B (CONSOLIDATION THERAPY \\[HDCSCR\\]): Within 6-8 weeks of the end of induction chemotherapy or second-look surgery, patients receive etoposide IV and thiotepa IV over 3 hours on days -5 to -3 and undergo peripheral blood stem cell (PBSC) transplant on day 0. Patients then undergo radiation therapy QD for 5 days weekly (20 fractions followed by a boost dose for 10 fractions) for 6 weeks in the absence of disease progression or unacceptable toxicity.\n\nPatients also undergo magnetic resonance imaging (MRI), as well as collection of cerebral spinal fluid (CSF) and blood sample throughout the trial.\n\nAfter completion of study treatment, patients are followed for up to 10 years."}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT'], 'maximumAge': '29 Years', 'minimumAge': '3 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Patients must be \\>= 3 years and \\< 30 years at the time of study enrollment\n* Patients must be newly diagnosed with localized primary CNS NGGCT of the suprasellar and/or pineal region by pathology and/or serum or cerebrospinal fluid (CSF) elevation of AFP above institutional normal or \\> 10 ng/mL or human chorionic gonadotropin (hCG) beta \\> 100 mIU/mL as confirmed by Rapid Central Marker Screening Review on APEC14B1-CNS. Suprasellar, pineal and bifocal tumors are included. (CSF tumor markers and cytology must be within 31 days prior to enrollment and start of protocol therapy \\[repeat if necessary\\]. Serum tumor markers, AFP and hCGbeta must be within 7 days prior to enrollment and start of protocol therapy \\[repeat if necessary\\]). Basal ganglia or other primary sites are excluded\n* Patients with any of the following pathological elements are eligible: endodermal sinus (yolk sac), embryonal carcinoma, choriocarcinoma, malignant/immature teratoma and mixed germ cell tumor (GCT) (i.e., may include some pure germinoma) if malignant elements listed above are present. Patients with only mature teratoma are excluded. Patients with pure germinoma admixed with mature teratoma are excluded (would be eligible for pure germinoma protocols)\n* Patients must have a cranial MRI with and without gadolinium at diagnosis/prior to enrollment. If surgical resection is performed, patients must have pre-operative and post operative brain MRI with and without gadolinium. The post operative brain MRI should be obtained within 72 hours of surgery. If patient has a biopsy only, post-operative brain MRI is recommended but not required (within 31 days prior to study enrollment and start of protocol therapy )\n* Patients must have a spine MRI with gadolinium obtained at diagnosis/prior to enrollment. Spine MRI with and without gadolinium is recommended (within 31 days prior to study enrollment and start of protocol therapy)\n* Lumbar CSF must be obtained prior to study enrollment unless medically contraindicated. If a patient undergoes surgery and lumbar CSF cytology cannot be obtained at the time of surgery, then it should be performed at least 10 days following surgery and prior to study enrollment. False positive cytology can occur within 10 days of surgery\n* Patients must have RAPID CENTRAL TUMOR MARKER REVIEW CSF tumor markers obtained prior to enrollment unless medically contraindicated. Ventricular CSF obtained at the time of CSF diversion procedure (if performed) is acceptable for tumor markers but lumbar CSF is preferred. In case CSF diversion and biopsy/surgery are combined, CSF tumor markers should be collected first\n* Peripheral absolute neutrophil count (ANC) \\>= 1000/uL (within 7 days prior to enrollment)\n* Platelet count \\>= 100,000/uL (transfusion independent) (within 7 days prior to enrollment)\n* Hemoglobin \\>= 8.0 g/dL (may receive red blood cell \\[RBC\\] transfusions) (within 7 days prior to enrollment)\n* Creatinine clearance or radioisotope glomerular filtration rate (GFR) \\>= 70 mL/min/1.73 m\\^2 or a serum creatinine based on age/gender as follows (within 7 days prior to enrollment):\n\n * Age: Maximum serum creatinine (mg/dL)\n\n * 3 to \\< 6 years: 0.8 (male), 0.8 (female)\n * 6 to \\< 10 years: 1 (male), 1 (female)\n * 10 to \\< 13 years: 1.2 (male), 1.2 (female)\n * 13 to \\< 16 years: 1.5 (male), 1.4 (female)\n * \\>= 16 years: male (1.7), 1.4 (female)\n* Total bilirubin =\\< 1.5 x upper limit of normal (ULN) for age (within 7 days prior to enrollment)\n* Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase \\[ALT\\]) =\\< 135 U/L (within 7 days prior to enrollment)\n\n * Note: For the purpose of this study, the ULN for SGPT (ALT) has been set to the value of 45 U/L\n* Central nervous system function defined as:\n\n * Patients with seizure disorder may be enrolled if on anticonvulsants and well controlled\n * Patients must not be in status epilepticus, coma or assisted ventilation prior to study enrollment\n* Protocol therapy must begin within 31 calendar days of definitive surgery or clinical diagnosis, whichever is later. If a biopsy only was performed, the biopsy date will be considered the date of definitive surgery. For patients who have a biopsy or incomplete resection at diagnosis followed by additional surgery, the date of the last resection will be considered the date of definitive surgery.\n* All patients and/or their parents or legal guardians must sign a written informed consent\n* All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met\n* NEUROCOGNITIVE FUNCTION AND QUALITY OF LIFE ASSESSMENT:\n* English-, Spanish-, or French- speaking\n\n * Note: Patients who speak a language other than English, Spanish, or French will be allowed to participate in ACNS2021 but will not complete the neurocognitive and quality of life assessments\n* No known history of neurodevelopmental disorder prior to diagnosis of NGGCT (e.g., Down syndrome, fragile X, William syndrome, intellectual disability). Patients with NF1 will be allowed to participate\n* Additional eligibility criteria for the COG Standardized Neuropsychological Battery only: must be at a site that has a psychologist to administer the battery\n\n * Note: If not eligible for the COG Standardized Battery, patients should still complete the Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2), Pediatric Quality of Life Inventory (PedsQL), Adaptive Behavior Assessment System Third Edition (ABAS-3), and Behavior Assessment System for Children, Third Edition (BASC-3) questionnaires\n\nExclusion Criteria:\n\n* Patients with tumors located outside the ventricles (i.e., basal ganglia, thalamus)\n* Patients with only mature teratoma and non-elevated markers upon tumor sampling at diagnosis\n* Patients who have received any prior tumor-directed therapy for their diagnosis of NGGCT other than surgical intervention and corticosteroids\n* Patients with metastatic disease (i.e., MRI evaluation, lumbar CSF cytology or intraoperative evidence of dissemination)\n* Female patients who are pregnant, since fetal toxicities and teratogenic effects have been noted for several of the study drugs\n\n * Note: Serum and urine pregnancy tests may be falsely positive due to HCGbeta-secreting germ cell tumors. Ensure the patient is not pregnant by institutional standards\n* Lactating females who plan to breastfeed their infants\n* Sexually active patients of reproductive potential who have not agreed to use an effective contraceptive method for the duration of their study participation'}, 'identificationModule': {'nctId': 'NCT04684368', 'briefTitle': 'A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT', 'organization': {'class': 'NETWORK', 'fullName': "Children's Oncology Group"}, 'officialTitle': 'A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular &Amp; Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor', 'orgStudyIdInfo': {'id': 'ACNS2021'}, 'secondaryIdInfos': [{'id': 'NCI-2020-13175', 'type': 'REGISTRY', 'domain': 'CTRP (Clinical Trial Reporting Program)'}, {'id': 'ACNS2021', 'type': 'OTHER', 'domain': "Children's Oncology Group"}, {'id': 'ACNS2021', 'type': 'OTHER', 'domain': 'CTEP'}, {'id': 'U10CA180886', 'link': 'https://reporter.nih.gov/quickSearch/U10CA180886', 'type': 'NIH'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Plan A (chemotherapy, WVSCI, second-look surgery if needed)', 'description': 'See Outline in Detailed Description.', 'interventionNames': ['Procedure: Biospecimen Collection', 'Drug: Carboplatin', 'Drug: Etoposide', 'Biological: Filgrastim', 'Drug: Ifosfamide', 'Procedure: Magnetic Resonance Imaging', 'Drug: Mesna', 'Biological: Pegfilgrastim', 'Other: Questionnaire Administration', 'Radiation: Radiation Therapy', 'Procedure: Second-Look Surgery']}, {'type': 'EXPERIMENTAL', 'label': 'Plan B (chemotherapy, HDCSCR, second-look surgery if needed)', 'description': 'See Outline in Detailed Description.', 'interventionNames': ['Procedure: Biospecimen Collection', 'Drug: Carboplatin', 'Drug: Etoposide', 'Biological: Filgrastim', 'Drug: Ifosfamide', 'Procedure: Magnetic Resonance Imaging', 'Drug: Mesna', 'Biological: Pegfilgrastim', 'Procedure: Peripheral Blood Stem Cell Transplantation', 'Other: Questionnaire Administration', 'Radiation: Radiation Therapy', 'Procedure: Second-Look Surgery', 'Drug: Thiotepa']}], 'interventions': [{'name': 'Biospecimen Collection', 'type': 'PROCEDURE', 'otherNames': ['Biological Sample Collection', 'Biospecimen Collected', 'Specimen Collection'], 'description': 'Undergo collection of CSF and blood samples', 'armGroupLabels': ['Plan A (chemotherapy, WVSCI, second-look surgery if needed)', 'Plan B (chemotherapy, HDCSCR, second-look surgery if needed)']}, {'name': 'Carboplatin', 'type': 'DRUG', 'otherNames': ['Blastocarb', 'Carboplat', 'Carboplatin Hexal', 'Carboplatino', 'Carboplatinum', 'Carbosin', 'Carbosol', 'Carbotec', 'CBDCA', 'Displata', 'Ercar', 'JM-8', 'JM8', 'Nealorin', 'Novoplatinum', 'Paraplatin', 'Paraplatin AQ', 'Paraplatine', 'Platinwas', 'Ribocarbo'], 'description': 'Given IV', 'armGroupLabels': ['Plan A (chemotherapy, WVSCI, second-look surgery if needed)', 'Plan B (chemotherapy, HDCSCR, second-look surgery if needed)']}, {'name': 'Etoposide', 'type': 'DRUG', 'otherNames': ['Demethyl Epipodophyllotoxin Ethylidine Glucoside', 'EPEG', 'Lastet', 'Toposar', 'Vepesid', 'VP 16', 'VP 16-213', 'VP 16213', 'VP-16', 'VP-16-213', 'VP-16213', 'VP16', 'VP16213'], 'description': 'Given IV', 'armGroupLabels': ['Plan A (chemotherapy, WVSCI, second-look surgery if needed)', 'Plan B (chemotherapy, HDCSCR, second-look surgery if needed)']}, {'name': 'Filgrastim', 'type': 'BIOLOGICAL', 'otherNames': ['Filgrastim Biosimilar Filgrastim-sndz', 'Filgrastim Biosimilar Tbo-filgrastim', 'Filgrastim XM02', 'Filgrastim-aafi', 'Filgrastim-ayow', 'Filgrastim-sndz', 'G-CSF', 'Granix', 'Neupogen', 'Neutroval', 'Nivestim', 'Nivestym', 'r-metHuG-CSF', 'Recombinant Methionyl Human Granulocyte Colony Stimulating Factor', 'Releuko', 'rG-CSF', 'Tbo-filgrastim', 'Tevagrastim', 'XM02', 'Zarxio'], 'description': 'Given subcutaneously (SC) or IV', 'armGroupLabels': ['Plan A (chemotherapy, WVSCI, second-look surgery if needed)', 'Plan B (chemotherapy, HDCSCR, second-look surgery if needed)']}, {'name': 'Ifosfamide', 'type': 'DRUG', 'otherNames': ['Asta Z 4942', 'Asta Z-4942', 'Cyfos', 'Holoxan', 'Holoxane', 'Ifex', 'IFO', 'IFO-Cell', 'Ifolem', 'Ifomida', 'Ifomide', 'Ifosfamidum', 'Ifoxan', 'IFX', 'Iphosphamid', 'Iphosphamide', 'Iso-Endoxan', 'Isoendoxan', 'Isophosphamide', 'Mitoxana', 'MJF 9325', 'MJF-9325', 'Naxamide', 'Seromida', 'Tronoxal', 'Z 4942', 'Z-4942'], 'description': 'Given IV', 'armGroupLabels': ['Plan A (chemotherapy, WVSCI, second-look surgery if needed)', 'Plan B (chemotherapy, HDCSCR, second-look surgery if needed)']}, {'name': 'Magnetic Resonance Imaging', 'type': 'PROCEDURE', 'otherNames': ['Magnetic Resonance', 'Magnetic Resonance Imaging (MRI)', 'Magnetic resonance imaging (procedure)', 'Magnetic Resonance Imaging Scan', 'Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance', 'MR', 'MR Imaging', 'MRI', 'MRI Scan', 'MRIs', 'NMR Imaging', 'NMRI', 'Nuclear Magnetic Resonance Imaging', 'sMRI', 'Structural MRI'], 'description': 'Undergo MRI', 'armGroupLabels': ['Plan A (chemotherapy, WVSCI, second-look surgery if needed)', 'Plan B (chemotherapy, HDCSCR, second-look surgery if needed)']}, {'name': 'Mesna', 'type': 'DRUG', 'otherNames': ['2-Mercaptoethanesulfonate, Sodium Salt', 'Ausobronc', 'D-7093', 'Filesna', 'Mercaptoethane Sulfonate', 'Mercaptoethanesulfonate', 'Mesnex', 'Mesnil', 'Mesnum', 'Mexan', 'Mistabron', 'Mistabronco', 'Mitexan', 'Mucofluid', 'Mucolene', 'UCB 3983', 'Uromitexan', 'Ziken'], 'description': 'Given IV or orally', 'armGroupLabels': ['Plan A (chemotherapy, WVSCI, second-look surgery if needed)', 'Plan B (chemotherapy, HDCSCR, second-look surgery if needed)']}, {'name': 'Pegfilgrastim', 'type': 'BIOLOGICAL', 'otherNames': ['Dulastin', 'Filgrastim SD-01', 'filgrastim-SD/01', 'Fulphila', 'Fylnetra', 'G-Lasta', 'HSP-130', 'Jinyouli', 'Neulasta', 'Neulastim', 'Neupopeg', 'Nyvepria', 'PEG-filgrastim', 'Pegcyte', 'Pegfilgrastim Biosimilar HSP-130', 'Pegfilgrastim Biosimilar Nyvepria', 'Pegfilgrastim Biosimilar Pegcyte', 'Pegfilgrastim Biosimilar PF-06881894', 'Pegfilgrastim Biosimilar Udenyca', 'Pegfilgrastim Biosimilar Ziextenzo', 'Pegfilgrastim-apgf', 'Pegfilgrastim-bmez', 'Pegfilgrastim-cbqv', 'Pegfilgrastim-fpgk', 'Pegfilgrastim-jmdb', 'Pegfilgrastim-pbbk', 'Pegylated G-CSF', 'Pegylated GCSF', 'Pegylated Granulocyte Colony Stimulating Factor', 'PF-06881894', 'SD-01', 'SD-01 sustained duration G-CSF', 'Stimufend', 'Tripegfilgrastim', 'Udenyca', 'Ziextenzo'], 'description': 'Given SC', 'armGroupLabels': ['Plan A (chemotherapy, WVSCI, second-look surgery if needed)', 'Plan B (chemotherapy, HDCSCR, second-look surgery if needed)']}, {'name': 'Peripheral Blood Stem Cell Transplantation', 'type': 'PROCEDURE', 'otherNames': ['PBPC transplantation', 'PBSCT', 'Peripheral Blood', 'Peripheral Blood Progenitor Cell Transplantation', 'PERIPHERAL BLOOD STEM CELL TRANSPLANT', 'Peripheral Stem Cell Support', 'Peripheral Stem Cell Transplant', 'Peripheral Stem Cell Transplantation'], 'description': 'Undergo PBSC transplant', 'armGroupLabels': ['Plan B (chemotherapy, HDCSCR, second-look surgery if needed)']}, {'name': 'Questionnaire Administration', 'type': 'OTHER', 'description': 'Ancillary studies', 'armGroupLabels': ['Plan A (chemotherapy, WVSCI, second-look surgery if needed)', 'Plan B (chemotherapy, HDCSCR, second-look surgery if needed)']}, {'name': 'Radiation Therapy', 'type': 'RADIATION', 'otherNames': ['Cancer Radiotherapy', 'Energy Type', 'ENERGY_TYPE', 'Irradiate', 'Irradiated', 'Irradiation', 'Radiation', 'Radiation Therapy, NOS', 'Radiotherapeutics', 'Radiotherapy', 'RT', 'Therapy, Radiation'], 'description': 'Undergo WVSCI radiation therapy', 'armGroupLabels': ['Plan A (chemotherapy, WVSCI, second-look surgery if needed)']}, {'name': 'Radiation Therapy', 'type': 'RADIATION', 'otherNames': ['Cancer Radiotherapy', 'Energy Type', 'ENERGY_TYPE', 'Irradiate', 'Irradiated', 'Irradiation', 'Radiation', 'Radiation Therapy, NOS', 'Radiotherapeutics', 'Radiotherapy', 'RT', 'Therapy, Radiation'], 'description': 'Undergo radiation therapy', 'armGroupLabels': ['Plan B (chemotherapy, HDCSCR, second-look surgery if needed)']}, {'name': 'Second-Look Surgery', 'type': 'PROCEDURE', 'otherNames': ['Reoperation', 'Repeat Surgery', 'Second Look', 'Surgical Revision'], 'description': 'Undergo second-look surgery if needed', 'armGroupLabels': ['Plan A (chemotherapy, WVSCI, second-look surgery if needed)', 'Plan B (chemotherapy, HDCSCR, second-look surgery if needed)']}, {'name': 'Thiotepa', 'type': 'DRUG', 'otherNames': ["1,1',1''-Phosphinothioylidynetrisaziridine", 'Girostan', "N,N', N''-Triethylenethiophosphoramide", 'Oncotiotepa', 'SH 105', 'SH-105', 'SH105', 'STEPA', 'Tepadina', 'Tepylute', 'TESPA', 'Tespamin', 'Tespamine', 'Thio-Tepa', 'Thiofosfamide', 'Thiofozil', 'Thiophosphamide', 'Thiophosphoamide', 'Thiophosphoramide', 'Thiotef', 'Tifosyl', 'TIO TEF', 'Tio-tef', 'Triethylene Thiophosphoramide', 'Triethylenethiophosphoramide', 'Tris(1-aziridinyl)phosphine sulfide', 'TSPA', 'WR 45312'], 'description': 'Given IV', 'armGroupLabels': ['Plan B (chemotherapy, HDCSCR, second-look surgery if needed)']}]}, 'contactsLocationsModule': {'locations': [{'zip': '35233', 'city': 'Birmingham', 'state': 'Alabama', 'status': 'SUSPENDED', 'country': 'United States', 'facility': "Children's Hospital of Alabama", 'geoPoint': {'lat': 33.52066, 'lon': -86.80249}}, {'zip': '99508', 'city': 'Anchorage', 'state': 'Alaska', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'AKPAMC.OncologyResearchSupport@providence.org', 'phone': '907-212-6871'}, {'name': 'Brenda J. Wittman', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Providence Alaska Medical Center', 'geoPoint': {'lat': 61.21806, 'lon': -149.90028}}, {'zip': '85202', 'city': 'Mesa', 'state': 'Arizona', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '480-412-3100'}, {'name': 'Joseph C. Torkildson', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Banner Children's at Desert", 'geoPoint': {'lat': 33.42227, 'lon': -111.82264}}, {'zip': '85016', 'city': 'Phoenix', 'state': 'Arizona', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '602-546-0920'}, {'name': 'Michael R. Mangum', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Phoenix Childrens Hospital', 'geoPoint': {'lat': 33.44838, 'lon': -112.07404}}, {'zip': '85719', 'city': 'Tucson', 'state': 'Arizona', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'UACC-IIT@uacc.arizona.edu'}, {'name': 'Holly E. Pariury', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Banner University Medical Center - Tucson', 'geoPoint': {'lat': 32.22174, 'lon': -110.92648}}, {'zip': '85719', 'city': 'Tucson', 'state': 'Arizona', 'status': 'SUSPENDED', 'country': 'United States', 'facility': 'University of Arizona Cancer Center-North Campus', 'geoPoint': {'lat': 32.22174, 'lon': -110.92648}}, {'zip': '72202-3591', 'city': 'Little Rock', 'state': 'Arkansas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '501-364-7373'}, {'name': 'David L. Becton', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Arkansas Children's Hospital", 'geoPoint': {'lat': 34.74648, 'lon': -92.28959}}, {'zip': '90242', 'city': 'Downey', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '626-564-3455'}, {'name': 'Hung N. Tran', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Kaiser Permanente Downey Medical Center', 'geoPoint': {'lat': 33.94001, 'lon': -118.13257}}, {'zip': '92354', 'city': 'Loma Linda', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '909-558-4050'}, {'name': 'Albert Kheradpour', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Loma Linda University Medical Center', 'geoPoint': {'lat': 34.04835, 'lon': -117.26115}}, {'zip': '90806', 'city': 'Long Beach', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '562-933-5600'}, {'name': 'Jacqueline N. Casillas', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Miller Children's and Women's Hospital Long Beach", 'geoPoint': {'lat': 33.76696, 'lon': -118.18923}}, {'zip': '90027', 'city': 'Los Angeles', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '323-361-4110'}, {'name': 'Tom B. Davidson', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Children's Hospital Los Angeles", 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '90027', 'city': 'Los Angeles', 'state': 'California', 'status': 'SUSPENDED', 'country': 'United States', 'facility': 'Kaiser Permanente Los Angeles Medical Center', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '90048', 'city': 'Los Angeles', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '310-423-8965'}, {'name': 'Fataneh (Fae) Majlessipour', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Cedars Sinai Medical Center', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '93636', 'city': 'Madera', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'Research@valleychildrens.org', 'phone': '559-353-3000'}, {'name': 'Ruetima Titapiwatanakun', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Valley Children's Hospital", 'geoPoint': {'lat': 36.96134, 'lon': -120.06072}}, {'zip': '94611', 'city': 'Oakland', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'Kpoct@kp.org', 'phone': '877-642-4691'}, {'name': 'Aarati V. Rao', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Kaiser Permanente-Oakland', 'geoPoint': {'lat': 37.80437, 'lon': -122.2708}}, {'zip': '92868', 'city': 'Orange', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'oncresearch@choc.org', 'phone': '714-509-8646'}, {'name': 'Elyssa M. Rubin', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Children's Hospital of Orange County", 'geoPoint': {'lat': 33.78779, 'lon': -117.85311}}, {'zip': '94304', 'city': 'Palo Alto', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'ccto-office@stanford.edu', 'phone': '800-694-0012'}, {'name': 'Jay Michael S. Balagtas', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Lucile Packard Children's Hospital Stanford University", 'geoPoint': {'lat': 37.44188, 'lon': -122.14302}}, {'zip': '92123', 'city': 'San Diego', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '858-966-5934'}, {'name': 'William D. Roberts', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Rady Children's Hospital - San Diego", 'geoPoint': {'lat': 32.71571, 'lon': -117.16472}}, {'zip': '94158', 'city': 'San Francisco', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'cancertrials@ucsf.edu', 'phone': '877-827-3222'}, {'name': 'Alyssa T. Reddy', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'UCSF Medical Center-Mission Bay', 'geoPoint': {'lat': 37.77493, 'lon': -122.41942}}, {'zip': '80045', 'city': 'Aurora', 'state': 'Colorado', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'josh.b.gordon@nsmtp.kp.org', 'phone': '303-764-5056'}, {'name': 'Holly B. Lindsay', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Children's Hospital Colorado", 'geoPoint': {'lat': 39.72943, 'lon': -104.83192}}, {'zip': '06106', 'city': 'Hartford', 'state': 'Connecticut', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '860-545-9981'}, {'name': 'Michael S. Isakoff', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Connecticut Children's Medical Center", 'geoPoint': {'lat': 41.76371, 'lon': -72.68509}}, {'zip': '06520', 'city': 'New Haven', 'state': 'Connecticut', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'canceranswers@yale.edu', 'phone': '203-785-5702'}, {'name': 'Asher M. Marks', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Yale University', 'geoPoint': {'lat': 41.30815, 'lon': -72.92816}}, {'zip': '19803', 'city': 'Wilmington', 'state': 'Delaware', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'Allison.bruce@nemours.org', 'phone': '302-651-5572'}, {'name': 'Scott M. Bradfield', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Alfred I duPont Hospital for Children', 'geoPoint': {'lat': 39.74595, 'lon': -75.54659}}, {'zip': '20010', 'city': 'Washington D.C.', 'state': 'District of Columbia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'OncCRC_OnCall@childrensnational.org', 'phone': '202-476-2800'}, {'name': 'Jeffrey S. Dome', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Children's National Medical Center", 'geoPoint': {'lat': 38.89511, 'lon': -77.03637}}, {'zip': '33908', 'city': 'Fort Myers', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'molly.arnstrom@leehealth.org', 'phone': '239-343-5333'}, {'name': 'Emad K. Salman', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Golisano Children's Hospital of Southwest Florida", 'geoPoint': {'lat': 26.62168, 'lon': -81.84059}}, {'zip': '32610', 'city': 'Gainesville', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'cancer-center@ufl.edu', 'phone': '352-273-8010'}, {'name': 'Brian Stover', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'UF Health Cancer Institute - Gainesville', 'geoPoint': {'lat': 29.65163, 'lon': -82.32483}}, {'zip': '32207', 'city': 'Jacksonville', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'Allison.bruce@nemours.org', 'phone': '302-651-5572'}, {'name': 'Scott M. Bradfield', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Nemours Children's Clinic-Jacksonville", 'geoPoint': {'lat': 30.33218, 'lon': -81.65565}}, {'zip': '33136', 'city': 'Miami', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '305-243-2647'}, {'name': 'Bradley Gampel', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Miami Miller School of Medicine-Sylvester Cancer Center', 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'zip': '33155', 'city': 'Miami', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '888-624-2778'}, {'name': 'Ziad A. Khatib', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Nicklaus Children's Hospital", 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'zip': '32806', 'city': 'Orlando', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'Jennifer.spinelli@orlandohealth.com', 'phone': '321-841-5357'}, {'name': 'Jaime M. Libes-Bander', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Arnold Palmer Hospital for Children', 'geoPoint': {'lat': 28.53834, 'lon': -81.37924}}, {'zip': '32827', 'city': 'Orlando', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'Allison.bruce@nemours.org', 'phone': '302-651-5572'}, {'name': 'Scott M. Bradfield', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Nemours Children's Hospital", 'geoPoint': {'lat': 28.53834, 'lon': -81.37924}}, {'zip': '32504', 'city': 'Pensacola', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'helpdesk@childrensoncologygroup.org'}, {'name': 'Jeffrey H. Schwartz', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Nemours Children's Clinic - Pensacola", 'geoPoint': {'lat': 30.42131, 'lon': -87.21691}}, {'zip': '32504', 'city': 'Pensacola', 'state': 'Florida', 'status': 'SUSPENDED', 'country': 'United States', 'facility': 'Sacred Heart Hospital', 'geoPoint': {'lat': 30.42131, 'lon': -87.21691}}, {'zip': '33701', 'city': 'St. Petersburg', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'Ashley.Repp@jhmi.edu', 'phone': '727-767-4784'}, {'name': 'Stacie L. Stapleton', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Johns Hopkins All Children's Hospital", 'geoPoint': {'lat': 27.77086, 'lon': -82.67927}}, {'zip': '33607', 'city': 'Tampa', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'jennifer.manns@baycare.org', 'phone': '813-357-0849'}, {'name': 'Don E. Eslin', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Saint Joseph's Hospital/Children's Hospital-Tampa", 'geoPoint': {'lat': 27.94752, 'lon': -82.45843}}, {'zip': '30329', 'city': 'Atlanta', 'state': 'Georgia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'Olivia.Floyd@choa.org', 'phone': '404-785-0232'}, {'name': 'Jason R. Fangusaro', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Children's Healthcare of Atlanta - Arthur M Blank Hospital", 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'zip': '96826', 'city': 'Honolulu', 'state': 'Hawaii', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '808-983-6090'}, {'name': 'Wade T. Kyono', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Kapiolani Medical Center for Women and Children', 'geoPoint': {'lat': 21.30694, 'lon': -157.85833}}, {'zip': '83712', 'city': 'Boise', 'state': 'Idaho', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'eslinget@slhs.org', 'phone': '208-381-2774'}, {'name': 'Martha M. Pacheco', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Saint Luke's Cancer Institute - Boise", 'geoPoint': {'lat': 43.6135, 'lon': -116.20345}}, {'zip': '60611', 'city': 'Chicago', 'state': 'Illinois', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '773-880-4562'}, {'name': 'Alicia Lenzen', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Lurie Children's Hospital-Chicago", 'geoPoint': {'lat': 41.85003, 'lon': -87.65005}}, {'zip': '60612', 'city': 'Chicago', 'state': 'Illinois', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '312-355-3046'}, {'name': 'Dipti S. Dighe', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Illinois', 'geoPoint': {'lat': 41.85003, 'lon': -87.65005}}, {'zip': '60637', 'city': 'Chicago', 'state': 'Illinois', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'cancerclinicaltrials@bsd.uchicago.edu', 'phone': '773-702-8222'}, {'name': 'Wendy S. Darlington', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Chicago Comprehensive Cancer Center', 'geoPoint': {'lat': 41.85003, 'lon': -87.65005}}, {'zip': '60153', 'city': 'Maywood', 'state': 'Illinois', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '708-226-4357'}, {'name': 'Eugene Suh', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Loyola University Medical Center', 'geoPoint': {'lat': 41.8792, 'lon': -87.84312}}, {'zip': '61637', 'city': 'Peoria', 'state': 'Illinois', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '888-226-4343'}, {'name': 'Prerna Kumar', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Saint Jude Midwest Affiliate', 'geoPoint': {'lat': 40.69365, 'lon': -89.58899}}, {'zip': '46202', 'city': 'Indianapolis', 'state': 'Indiana', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Sandeep Batra', 'role': 'CONTACT', 'email': 'batras@iu.edu', 'phone': '317-944-8784'}, {'name': 'Sandeep Batra', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Riley Hospital for Children', 'geoPoint': {'lat': 39.76838, 'lon': -86.15804}}, {'zip': '50309', 'city': 'Des Moines', 'state': 'Iowa', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'samantha.mallory@unitypoint.org', 'phone': '515-241-8912'}, {'name': 'Samantha L. Mallory', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Blank Children's Hospital", 'geoPoint': {'lat': 41.60054, 'lon': -93.60911}}, {'zip': '52242', 'city': 'Iowa City', 'state': 'Iowa', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '800-237-1225'}, {'name': 'David S. Dickens', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Iowa/Holden Comprehensive Cancer Center', 'geoPoint': {'lat': 41.66113, 'lon': -91.53017}}, {'zip': '40536', 'city': 'Lexington', 'state': 'Kentucky', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '859-257-3379'}, {'name': 'James T. Badgett', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Kentucky/Markey Cancer Center', 'geoPoint': {'lat': 37.98869, 'lon': -84.47772}}, {'zip': '40202', 'city': 'Louisville', 'state': 'Kentucky', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'CancerResource@nortonhealthcare.org', 'phone': '502-629-5500'}, {'name': 'Michael J. Ferguson', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Norton Children's Hospital", 'geoPoint': {'lat': 38.25424, 'lon': -85.75941}}, {'zip': '70121', 'city': 'New Orleans', 'state': 'Louisiana', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'Elisemarie.curry@ochsner.org', 'phone': '504-842-8084'}, {'name': 'Craig Lotterman', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Ochsner Medical Center Jefferson', 'geoPoint': {'lat': 29.95465, 'lon': -90.07507}}, {'zip': '04401', 'city': 'Bangor', 'state': 'Maine', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '207-973-4274'}, {'name': 'Daniel L. Callaway', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Eastern Maine Medical Center', 'geoPoint': {'lat': 44.79884, 'lon': -68.77265}}, {'zip': '04074', 'city': 'Scarborough', 'state': 'Maine', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'clinicalresearch@mainehealth.org', 'phone': '207-396-8670'}, {'name': 'Stanley Chaleff', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Maine Children's Cancer Program", 'geoPoint': {'lat': 43.57814, 'lon': -70.32172}}, {'zip': '21215', 'city': 'Baltimore', 'state': 'Maryland', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '410-601-9083'}, {'name': 'Jason M. Fixler', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Sinai Hospital of Baltimore', 'geoPoint': {'lat': 39.29038, 'lon': -76.61219}}, {'zip': '21287', 'city': 'Baltimore', 'state': 'Maryland', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'jhcccro@jhmi.edu', 'phone': '410-955-8804'}, {'name': 'Kenneth J. Cohen', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Johns Hopkins University/Sidney Kimmel Cancer Center', 'geoPoint': {'lat': 39.29038, 'lon': -76.61219}}, {'zip': '02114', 'city': 'Boston', 'state': 'Massachusetts', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '877-726-5130'}, {'name': 'Laura Wiltsie', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Massachusetts General Hospital Cancer Center', 'geoPoint': {'lat': 42.35843, 'lon': -71.05977}}, {'zip': '02215', 'city': 'Boston', 'state': 'Massachusetts', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '877-442-3324'}, {'name': 'Kee Kiat Yeo', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Dana-Farber Cancer Institute', 'geoPoint': {'lat': 42.35843, 'lon': -71.05977}}, {'zip': '48109', 'city': 'Ann Arbor', 'state': 'Michigan', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '800-865-1125'}, {'name': 'Andrea T. Franson', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "C S Mott Children's Hospital", 'geoPoint': {'lat': 42.27756, 'lon': -83.74088}}, {'zip': '48201', 'city': 'Detroit', 'state': 'Michigan', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'helpdesk@childrensoncologygroup.org'}, {'name': 'Stephanie A. Toll', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Children's Hospital of Michigan", 'geoPoint': {'lat': 42.33143, 'lon': -83.04575}}, {'zip': '48823', 'city': 'East Lansing', 'state': 'Michigan', 'status': 'ACTIVE_NOT_RECRUITING', 'country': 'United States', 'facility': 'Michigan State University', 'geoPoint': {'lat': 42.73698, 'lon': -84.48387}}, {'zip': '49503', 'city': 'Grand Rapids', 'state': 'Michigan', 'status': 'SUSPENDED', 'country': 'United States', 'facility': 'Corewell Health Grand Rapids Hospitals - Butterworth Hospital', 'geoPoint': {'lat': 42.96336, 'lon': -85.66809}}, {'zip': '49503', 'city': 'Grand Rapids', 'state': 'Michigan', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'crcwm-regulatory@crcwm.org', 'phone': '616-391-1230'}, {'name': 'Kathleen Y. Butler', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital", 'geoPoint': {'lat': 42.96336, 'lon': -85.66809}}, {'zip': '48073', 'city': 'Royal Oak', 'state': 'Michigan', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '248-551-7695'}, {'name': 'Marie V. Nelson', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Corewell Health Children's", 'geoPoint': {'lat': 42.48948, 'lon': -83.14465}}, {'zip': '55404', 'city': 'Minneapolis', 'state': 'Minnesota', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'pauline.mitby@childrensmn.org', 'phone': '612-813-5913'}, {'name': 'Michael K. Richards', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Children's Hospitals and Clinics of Minnesota - Minneapolis", 'geoPoint': {'lat': 44.97997, 'lon': -93.26384}}, {'zip': '55905', 'city': 'Rochester', 'state': 'Minnesota', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '855-776-0015'}, {'name': 'Joseph Z. Wilson', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Mayo Clinic in Rochester', 'geoPoint': {'lat': 44.02163, 'lon': -92.4699}}, {'zip': '39216', 'city': 'Jackson', 'state': 'Mississippi', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '601-815-6700'}, {'name': 'Betty L. Herrington', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Mississippi Medical Center', 'geoPoint': {'lat': 32.29876, 'lon': -90.18481}}, {'zip': '65212', 'city': 'Columbia', 'state': 'Missouri', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'snwq62@health.missouri.edu', 'phone': '573-882-1960'}, {'name': 'Barbara A. Gruner', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "University of Missouri Children's Hospital", 'geoPoint': {'lat': 38.95171, 'lon': -92.33407}}, {'zip': '64108', 'city': 'Kansas City', 'state': 'Missouri', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'COGResearchGroup@cmh.edu', 'phone': '816-302-6808'}, {'name': 'Keith J. August', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Children's Mercy Hospitals and Clinics", 'geoPoint': {'lat': 39.09973, 'lon': -94.57857}}, {'zip': '63104', 'city': 'St Louis', 'state': 'Missouri', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '314-268-4000'}, {'name': 'William S. Ferguson', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Cardinal Glennon Children's Medical Center", 'geoPoint': {'lat': 38.62727, 'lon': -90.19789}}, {'zip': '63110', 'city': 'St Louis', 'state': 'Missouri', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'info@siteman.wustl.edu', 'phone': '800-600-3606'}, {'name': 'Mohamed S. Abdelbaki', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Washington University School of Medicine', 'geoPoint': {'lat': 38.62727, 'lon': -90.19789}}, {'zip': '63141', 'city': 'St Louis', 'state': 'Missouri', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '314-251-7066'}, {'name': 'Robin D. Hanson', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Mercy Hospital Saint Louis', 'geoPoint': {'lat': 38.62727, 'lon': -90.19789}}, {'zip': '68114', 'city': 'Omaha', 'state': 'Nebraska', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '402-955-3949'}, {'name': 'Jill C. Beck', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Children's Hospital and Medical Center of Omaha", 'geoPoint': {'lat': 41.25626, 'lon': -95.94043}}, {'zip': '68198', 'city': 'Omaha', 'state': 'Nebraska', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'unmcrsa@unmc.edu', 'phone': '402-559-6941'}, {'name': 'Jill C. Beck', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Nebraska Medical Center', 'geoPoint': {'lat': 41.25626, 'lon': -95.94043}}, {'zip': '89074', 'city': 'Henderson', 'state': 'Nevada', 'status': 'SUSPENDED', 'country': 'United States', 'facility': 'Oncology Las Vegas - Henderson', 'geoPoint': {'lat': 36.0397, 'lon': -114.98194}}, {'zip': '89135', 'city': 'Las Vegas', 'state': 'Nevada', 'status': 'SUSPENDED', 'country': 'United States', 'facility': 'Alliance for Childhood Diseases/Cure 4 the Kids Foundation', 'geoPoint': {'lat': 36.17497, 'lon': -115.13722}}, {'zip': '89502', 'city': 'Reno', 'state': 'Nevada', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'research@sncrf.org', 'phone': '702-384-0013'}, {'name': 'Alan K. Ikeda', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Renown Regional Medical Center', 'geoPoint': {'lat': 39.52963, 'lon': -119.8138}}, {'zip': '89511', 'city': 'Reno', 'state': 'Nevada', 'status': 'SUSPENDED', 'country': 'United States', 'facility': 'Cancer Care Specialists - Reno', 'geoPoint': {'lat': 39.52963, 'lon': -119.8138}}, {'zip': '03756', 'city': 'Lebanon', 'state': 'New Hampshire', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'cancer.research.nurse@dartmouth.edu', 'phone': '800-639-6918'}, {'name': 'Angela Ricci', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center', 'geoPoint': {'lat': 43.64229, 'lon': -72.25176}}, {'zip': '07601', 'city': 'Hackensack', 'state': 'New Jersey', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '551-996-2897'}, {'name': 'Derek R. Hanson', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Hackensack University Medical Center', 'geoPoint': {'lat': 40.88593, 'lon': -74.04347}}, {'zip': '07960', 'city': 'Morristown', 'state': 'New Jersey', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '973-971-5900'}, {'name': 'Kathryn L. Laurie', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Morristown Medical Center', 'geoPoint': {'lat': 40.79677, 'lon': -74.48154}}, {'zip': '08901', 'city': 'New Brunswick', 'state': 'New Jersey', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'kcovert@saintpetersuh.com', 'phone': '732-745-8600', 'phoneExt': '6163'}, {'name': 'Nibal A. Zaghloul', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Saint Peter's University Hospital", 'geoPoint': {'lat': 40.48622, 'lon': -74.45182}}, {'zip': '08903', 'city': 'New Brunswick', 'state': 'New Jersey', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '732-235-8675'}, {'name': 'Nehal S. Parikh', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital', 'geoPoint': {'lat': 40.48622, 'lon': -74.45182}}, {'zip': '07112', 'city': 'Newark', 'state': 'New Jersey', 'status': 'SUSPENDED', 'country': 'United States', 'facility': 'Newark Beth Israel Medical Center', 'geoPoint': {'lat': 40.73566, 'lon': -74.17237}}, {'zip': '07503', 'city': 'Paterson', 'state': 'New Jersey', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'HallL@sjhmc.org', 'phone': '973-754-2207'}, {'name': 'Alissa Kahn', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Saint Joseph's Regional Medical Center", 'geoPoint': {'lat': 40.91677, 'lon': -74.17181}}, {'zip': '12208', 'city': 'Albany', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '518-262-5513'}, {'name': 'Lauren R. Weintraub', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Albany Medical Center', 'geoPoint': {'lat': 42.65258, 'lon': -73.75623}}, {'zip': '11219', 'city': 'Brooklyn', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '718-765-2500'}, {'name': 'Mahmut Y. Celiker', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Maimonides Medical Center', 'geoPoint': {'lat': 40.6501, 'lon': -73.94958}}, {'zip': '11040', 'city': 'New Hyde Park', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '718-470-3460'}, {'name': 'Mark P. Atlas', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "The Steven and Alexandra Cohen Children's Medical Center of New York", 'geoPoint': {'lat': 40.7351, 'lon': -73.68791}}, {'zip': '10016', 'city': 'New York', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'CancerTrials@nyulangone.org'}, {'name': 'Elizabeth A. Raetz', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Laura and Isaac Perlmutter Cancer Center at NYU Langone', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '10065', 'city': 'New York', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '212-639-7592'}, {'name': 'Sameer Farouk Sait', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Memorial Sloan Kettering Cancer Center', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '11794', 'city': 'Stony Brook', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '800-862-2215'}, {'name': 'Laura E. Hogan', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Stony Brook University Medical Center', 'geoPoint': {'lat': 40.92565, 'lon': -73.14094}}, {'zip': '13210', 'city': 'Syracuse', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '315-464-5476'}, {'name': 'Melanie A. Comito', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'State University of New York Upstate Medical University', 'geoPoint': {'lat': 43.04812, 'lon': -76.14742}}, {'zip': '10461', 'city': 'The Bronx', 'state': 'New York', 'status': 'SUSPENDED', 'country': 'United States', 'facility': 'Montefiore Medical Center-Einstein Campus', 'geoPoint': {'lat': 40.84985, 'lon': -73.86641}}, {'zip': '10467', 'city': 'The Bronx', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'eskwak@montefiore.org', 'phone': '718-379-6866'}, {'name': 'Alice Lee', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Montefiore Medical Center - Moses Campus', 'geoPoint': {'lat': 40.84985, 'lon': -73.86641}}, {'zip': '10595', 'city': 'Valhalla', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '914-594-3794'}, {'name': 'Jessica C. Hochberg', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'New York Medical College', 'geoPoint': {'lat': 41.07482, 'lon': -73.77513}}, {'zip': '28203', 'city': 'Charlotte', 'state': 'North Carolina', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '800-804-9376'}, {'name': 'Joel A. Kaplan', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Carolinas Medical Center/Levine Cancer Institute', 'geoPoint': {'lat': 35.22709, 'lon': -80.84313}}, {'zip': '27710', 'city': 'Durham', 'state': 'North Carolina', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '888-275-3853'}, {'name': 'Jessica M. Sun', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Duke University Medical Center', 'geoPoint': {'lat': 35.99403, 'lon': -78.89862}}, {'zip': '27834', 'city': 'Greenville', 'state': 'North Carolina', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'eubankss@ecu.edu', 'phone': '252-744-1015'}, {'name': 'Andrea R. Whitfield', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'East Carolina University', 'geoPoint': {'lat': 35.61266, 'lon': -77.36635}}, {'zip': '27157', 'city': 'Winston-Salem', 'state': 'North Carolina', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '336-713-6771'}, {'name': 'Thomas W. McLean', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Wake Forest University Health Sciences', 'geoPoint': {'lat': 36.09986, 'lon': -80.24422}}, {'zip': '58122', 'city': 'Fargo', 'state': 'North Dakota', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'OncologyClinicalTrialsFargo@sanfordhealth.org', 'phone': '701-323-5760'}, {'name': 'Samuel J. Milanovich', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Sanford Broadway Medical Center', 'geoPoint': {'lat': 46.87719, 'lon': -96.7898}}, {'zip': '44308', 'city': 'Akron', 'state': 'Ohio', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '330-543-3193'}, {'name': 'Erin Wright', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Children's Hospital Medical Center of Akron", 'geoPoint': {'lat': 41.08144, 'lon': -81.51901}}, {'zip': '45229', 'city': 'Cincinnati', 'state': 'Ohio', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'cancer@cchmc.org', 'phone': '513-636-2799'}, {'name': 'Trent R. Hummel', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Cincinnati Children's Hospital Medical Center", 'geoPoint': {'lat': 39.12711, 'lon': -84.51439}}, {'zip': '44106', 'city': 'Cleveland', 'state': 'Ohio', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '216-844-5437'}, {'name': 'Duncan S. Stearns', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Rainbow Babies and Childrens Hospital', 'geoPoint': {'lat': 41.4995, 'lon': -81.69541}}, {'zip': '44195', 'city': 'Cleveland', 'state': 'Ohio', 'status': 'ACTIVE_NOT_RECRUITING', 'country': 'United States', 'facility': 'Cleveland Clinic Foundation', 'geoPoint': {'lat': 41.4995, 'lon': -81.69541}}, {'zip': '43205', 'city': 'Columbus', 'state': 'Ohio', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'Melinda.Triplet@nationwidechildrens.org', 'phone': '614-722-6039'}, {'name': 'Mark A. Ranalli', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Nationwide Children's Hospital", 'geoPoint': {'lat': 39.96118, 'lon': -82.99879}}, {'zip': '45404', 'city': 'Dayton', 'state': 'Ohio', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '800-228-4055'}, {'name': 'Jordan M. Wright', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Dayton Children's Hospital", 'geoPoint': {'lat': 39.75895, 'lon': -84.19161}}, {'zip': '43560', 'city': 'Sylvania', 'state': 'Ohio', 'status': 'SUSPENDED', 'country': 'United States', 'facility': 'ProMedica Flower Hospital', 'geoPoint': {'lat': 41.71894, 'lon': -83.71299}}, {'zip': '43606', 'city': 'Toledo', 'state': 'Ohio', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'PCIOncResearch@promedica.org', 'phone': '419-824-1842'}, {'name': 'Jamie L. Dargart', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital", 'geoPoint': {'lat': 41.66394, 'lon': -83.55521}}, {'zip': '73104', 'city': 'Oklahoma City', 'state': 'Oklahoma', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'ou-clinical-trials@ouhsc.edu', 'phone': '405-271-8777'}, {'name': 'Rene Y. McNall-Knapp', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Oklahoma Health Sciences Center', 'geoPoint': {'lat': 35.46756, 'lon': -97.51643}}, {'zip': '97227', 'city': 'Portland', 'state': 'Oregon', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '503-413-2560'}, {'name': 'Jason M. Glover', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Legacy Emanuel Children's Hospital", 'geoPoint': {'lat': 45.52345, 'lon': -122.67621}}, {'zip': '97239', 'city': 'Portland', 'state': 'Oregon', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'trials@ohsu.edu', 'phone': '503-494-1080'}, {'name': 'Linda C. Stork', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Oregon Health and Science University', 'geoPoint': {'lat': 45.52345, 'lon': -122.67621}}, {'zip': '18103', 'city': 'Allentown', 'state': 'Pennsylvania', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'Morgan_M.Horton@lvhn.org', 'phone': '610-402-9543'}, {'name': 'Jacob A. Troutman', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Lehigh Valley Hospital-Cedar Crest', 'geoPoint': {'lat': 40.60843, 'lon': -75.49018}}, {'zip': '17822', 'city': 'Danville', 'state': 'Pennsylvania', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'HemonCCTrials@geisinger.edu', 'phone': '570-271-5251'}, {'name': 'Jagadeesh Ramdas', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Geisinger Medical Center', 'geoPoint': {'lat': 40.96342, 'lon': -76.61273}}, {'zip': '17033', 'city': 'Hershey', 'state': 'Pennsylvania', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '717-531-6012'}, {'name': 'Lisa M. McGregor', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Penn State Children's Hospital", 'geoPoint': {'lat': 40.28592, 'lon': -76.65025}}, {'zip': '19134', 'city': 'Philadelphia', 'state': 'Pennsylvania', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '215-427-8991'}, {'name': 'Gregory E. Halligan', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Saint Christopher's Hospital for Children", 'geoPoint': {'lat': 39.95238, 'lon': -75.16362}}, {'zip': '15224', 'city': 'Pittsburgh', 'state': 'Pennsylvania', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'jean.tersak@chp.edu', 'phone': '412-692-8570'}, {'name': 'James T. Felker', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Children's Hospital of Pittsburgh of UPMC", 'geoPoint': {'lat': 40.44062, 'lon': -79.99589}}, {'zip': '02903', 'city': 'Providence', 'state': 'Rhode Island', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '401-444-1488'}, {'name': 'Bradley DeNardo', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Rhode Island Hospital', 'geoPoint': {'lat': 41.82399, 'lon': -71.41283}}, {'zip': '29425', 'city': 'Charleston', 'state': 'South Carolina', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'hcc-clinical-trials@musc.edu', 'phone': '843-792-9321'}, {'name': 'Jacqueline M. Kraveka', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Medical University of South Carolina', 'geoPoint': {'lat': 32.77632, 'lon': -79.93275}}, {'zip': '29203', 'city': 'Columbia', 'state': 'South Carolina', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'Kim.Williams3@prismahealth.org', 'phone': '864-522-4317'}, {'name': 'Stuart L. Cramer', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Prisma Health Richland Hospital', 'geoPoint': {'lat': 34.00071, 'lon': -81.03481}}, {'zip': '29605', 'city': 'Greenville', 'state': 'South Carolina', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'Kim.Williams3@prismahealth.org', 'phone': '864-522-4317'}, {'name': 'Aniket Saha', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "BI-LO Charities Children's Cancer Center", 'geoPoint': {'lat': 34.85262, 'lon': -82.39401}}, {'zip': '29605', 'city': 'Greenville', 'state': 'South Carolina', 'status': 'SUSPENDED', 'country': 'United States', 'facility': 'Prisma Health Cancer Institute - Faris', 'geoPoint': {'lat': 34.85262, 'lon': -82.39401}}, {'zip': '57117-5134', 'city': 'Sioux Falls', 'state': 'South Dakota', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'OncologyClinicalTrialsSF@SanfordHealth.org', 'phone': '605-312-3320'}, {'name': 'Kayelyn J. Wagner', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Sanford USD Medical Center - Sioux Falls', 'geoPoint': {'lat': 43.54369, 'lon': -96.72796}}, {'zip': '38105', 'city': 'Memphis', 'state': 'Tennessee', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'referralinfo@stjude.org', 'phone': '888-226-4343'}, {'name': 'Aditi Bagchi', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Saint Jude Children's Research Hospital", 'geoPoint': {'lat': 35.14953, 'lon': -90.04898}}, {'zip': '37203', 'city': 'Nashville', 'state': 'Tennessee', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '615-342-1919'}, {'name': 'Clinton M. Carroll', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "The Children's Hospital at TriStar Centennial", 'geoPoint': {'lat': 36.16589, 'lon': -86.78444}}, {'zip': '37232', 'city': 'Nashville', 'state': 'Tennessee', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '800-811-8480'}, {'name': 'Adam J. Esbenshade', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Vanderbilt University/Ingram Cancer Center', 'geoPoint': {'lat': 36.16589, 'lon': -86.78444}}, {'zip': '78723', 'city': 'Austin', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'TXAUS-DL-SFCHemonc.research@ascension.org', 'phone': '512-628-1902'}, {'name': 'Shannon M. Cohn', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Dell Children's Medical Center of Central Texas", 'geoPoint': {'lat': 30.26715, 'lon': -97.74306}}, {'zip': '78411', 'city': 'Corpus Christi', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'Crystal.DeLosSantos@dchstx.org', 'phone': '361-694-5311'}, {'name': 'Nkechi I. Mba', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Driscoll Children's Hospital", 'geoPoint': {'lat': 27.80058, 'lon': -97.39638}}, {'zip': '75230', 'city': 'Dallas', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '972-566-5588'}, {'name': 'Maurizio L. Ghisoli', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Medical City Dallas Hospital', 'geoPoint': {'lat': 32.78306, 'lon': -96.80667}}, {'zip': '75390', 'city': 'Dallas', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Daniel C. Bowers', 'role': 'CONTACT', 'email': 'Daniel.Bowers@utsouthwestern.edu', 'phone': '214-648-3896'}, {'name': 'Daniel C. Bowers', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'UT Southwestern/Simmons Cancer Center-Dallas', 'geoPoint': {'lat': 32.78306, 'lon': -96.80667}}, {'zip': '79905', 'city': 'El Paso', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'ranjan.bista@ttuhsc.edu', 'phone': '915-298-5444'}, {'name': 'Benjamin Carcamo', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "El Paso Children's Hospital", 'geoPoint': {'lat': 31.75872, 'lon': -106.48693}}, {'zip': '76104', 'city': 'Fort Worth', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'CookChildrensResearch@cookchildrens.org', 'phone': '682-885-2103'}, {'name': 'Sibo Zhao', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Cook Children's Medical Center", 'geoPoint': {'lat': 32.72541, 'lon': -97.32085}}, {'zip': '77030', 'city': 'Houston', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'burton@bcm.edu', 'phone': '713-798-1354'}, {'name': 'Jack M. Su', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center', 'geoPoint': {'lat': 29.76328, 'lon': -95.36327}}, {'zip': '77030', 'city': 'Houston', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Najat C. Daw', 'role': 'CONTACT', 'email': 'ndaw@mdanderson.org', 'phone': '713-792-6315'}, {'name': 'Najat C. Daw', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'M D Anderson Cancer Center', 'geoPoint': {'lat': 29.76328, 'lon': -95.36327}}, {'zip': '78207', 'city': 'San Antonio', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'bridget.medina@christushealth.org', 'phone': '210-704-2894'}, {'name': 'Julie Voeller', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Children's Hospital of San Antonio", 'geoPoint': {'lat': 29.42412, 'lon': -98.49363}}, {'zip': '78229', 'city': 'San Antonio', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'Vinod.GidvaniDiaz@hcahealthcare.com', 'phone': '210-575-6240'}, {'name': 'Jose M. Esquilin', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Methodist Children's Hospital of South Texas", 'geoPoint': {'lat': 29.42412, 'lon': -98.49363}}, {'zip': '78229', 'city': 'San Antonio', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'phoresearchoffice@uthscsa.edu', 'phone': '210-450-3800'}, {'name': 'Shafqat Shah', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Texas Health Science Center at San Antonio', 'geoPoint': {'lat': 29.42412, 'lon': -98.49363}}, {'zip': '84113', 'city': 'Salt Lake City', 'state': 'Utah', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '801-585-5270'}, {'name': 'Priya Chan', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Primary Children's Hospital", 'geoPoint': {'lat': 40.76078, 'lon': -111.89105}}, {'zip': '05405', 'city': 'Burlington', 'state': 'Vermont', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'rpo@uvm.edu', 'phone': '802-656-8990'}, {'name': 'Jessica L. Heath', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Vermont and State Agricultural College', 'geoPoint': {'lat': 44.47588, 'lon': -73.21207}}, {'zip': '22908', 'city': 'Charlottesville', 'state': 'Virginia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'uvacancertrials@hscmail.mcc.virginia.edu', 'phone': '434-243-6303'}, {'name': 'Brian C. Belyea', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Virginia Cancer Center', 'geoPoint': {'lat': 38.02931, 'lon': -78.47668}}, {'zip': '23507', 'city': 'Norfolk', 'state': 'Virginia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'CCBDCresearch@chkd.org', 'phone': '757-668-7243'}, {'name': 'Melissa S. Mark', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Children's Hospital of The King's Daughters", 'geoPoint': {'lat': 36.84681, 'lon': -76.28522}}, {'zip': '23298', 'city': 'Richmond', 'state': 'Virginia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'CTOclinops@vcu.edu', 'phone': '804-628-6430'}, {'name': 'Christopher Park', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'VCU Massey Comprehensive Cancer Center', 'geoPoint': {'lat': 37.55376, 'lon': -77.46026}}, {'zip': '24014', 'city': 'Roanoke', 'state': 'Virginia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'wpmccarty@carilionclinic.org', 'phone': '540-266-6238'}, {'name': 'Erwood G. Edwards', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Carilion Children's", 'geoPoint': {'lat': 37.27097, 'lon': -79.94143}}, {'zip': '98105', 'city': 'Seattle', 'state': 'Washington', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '866-987-2000'}, {'name': 'Sarah E. Leary', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Seattle Children's Hospital", 'geoPoint': {'lat': 47.60621, 'lon': -122.33207}}, {'zip': '99204', 'city': 'Spokane', 'state': 'Washington', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'HopeBeginsHere@providence.org', 'phone': '800-228-6618'}, {'name': 'Judy L. Felgenhauer', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Providence Sacred Heart Medical Center and Children's Hospital", 'geoPoint': {'lat': 47.65966, 'lon': -117.42908}}, {'zip': '98405', 'city': 'Tacoma', 'state': 'Washington', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'research@multicare.org', 'phone': '253-403-1461'}, {'name': 'Robert G. Irwin', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Mary Bridge Children's Hospital and Health Center", 'geoPoint': {'lat': 47.25288, 'lon': -122.44429}}, {'zip': '98431', 'city': 'Tacoma', 'state': 'Washington', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'melissa.a.forouhar.mil@health.mil', 'phone': '253-968-6144'}, {'name': 'Melissa A. Forouhar', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Madigan Army Medical Center', 'geoPoint': {'lat': 47.25288, 'lon': -122.44429}}, {'zip': '26506', 'city': 'Morgantown', 'state': 'West Virginia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'cancertrialsinfo@hsc.wvu.edu', 'phone': '304-293-7374'}, {'name': 'Ashley E. Meyer', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'West Virginia University Healthcare', 'geoPoint': {'lat': 39.62953, 'lon': -79.9559}}, {'zip': '53792', 'city': 'Madison', 'state': 'Wisconsin', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'clinicaltrials@cancer.wisc.edu', 'phone': '800-622-8922'}, {'name': 'Nicholas J. Pytel', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Wisconsin Carbone Cancer Center - University Hospital', 'geoPoint': {'lat': 43.07305, 'lon': -89.40123}}, {'zip': '54449', 'city': 'Marshfield', 'state': 'Wisconsin', 'status': 'SUSPENDED', 'country': 'United States', 'facility': 'Marshfield Medical Center-Marshfield', 'geoPoint': {'lat': 44.66885, 'lon': -90.1718}}, {'zip': '2031', 'city': 'Randwick', 'state': 'New South Wales', 'status': 'RECRUITING', 'country': 'Australia', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '(02) 9382-1721'}, {'name': 'Draga Barbaric', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Sydney Children's Hospital", 'geoPoint': {'lat': -33.91439, 'lon': 151.24895}}, {'zip': '2145', 'city': 'Westmead', 'state': 'New South Wales', 'status': 'RECRUITING', 'country': 'Australia', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '61-2-9845 1400'}, {'name': 'Bhavna Padhye', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "The Children's Hospital at Westmead", 'geoPoint': {'lat': -33.80383, 'lon': 150.98768}}, {'zip': '4101', 'city': 'South Brisbane', 'state': 'Queensland', 'status': 'RECRUITING', 'country': 'Australia', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '61 7 3068 1111'}, {'name': 'Steven A. Foresto', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Queensland Children's Hospital", 'geoPoint': {'lat': -27.48034, 'lon': 153.02049}}, {'zip': '3052', 'city': 'Parkville', 'state': 'Victoria', 'status': 'RECRUITING', 'country': 'Australia', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'Jordan.Hansford@rch.org.au', 'phone': '61 3 9345 5656'}, {'name': 'Martin A. Campbell', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Royal Children's Hospital", 'geoPoint': {'lat': -37.78333, 'lon': 144.95}}, {'zip': '6009', 'city': 'Perth', 'state': 'Western Australia', 'status': 'RECRUITING', 'country': 'Australia', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'helpdesk@childrensoncologygroup.org'}, {'name': 'Michelle Ng', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Perth Children's Hospital", 'geoPoint': {'lat': -31.95224, 'lon': 115.8614}}, {'zip': 'T3B 6A8', 'city': 'Calgary', 'state': 'Alberta', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'research4kids@ucalgary.ca', 'phone': '403-220-6898'}, {'name': 'Victor A. Lewis', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Alberta Children's Hospital", 'geoPoint': {'lat': 51.05011, 'lon': -114.08529}}, {'zip': 'T6G 2B7', 'city': 'Edmonton', 'state': 'Alberta', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'pedsoncologyresearch@ahs.ca', 'phone': '780-407-8798'}, {'name': 'Sarah J. McKillop', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Alberta Hospital', 'geoPoint': {'lat': 53.55014, 'lon': -113.46871}}, {'zip': 'V6H 3V4', 'city': 'Vancouver', 'state': 'British Columbia', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '604-875-2345', 'phoneExt': '6477'}, {'name': 'Rebecca J. Deyell', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "British Columbia Children's Hospital", 'geoPoint': {'lat': 49.24966, 'lon': -123.11934}}, {'zip': 'R3E 0V9', 'city': 'Winnipeg', 'state': 'Manitoba', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'ctu_web@cancercare.mb.ca', 'phone': '866-561-1026'}, {'name': 'Stephanie M. Villeneuve', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'CancerCare Manitoba', 'geoPoint': {'lat': 49.8844, 'lon': -97.14704}}, {'zip': 'B3K 6R8', 'city': 'Halifax', 'state': 'Nova Scotia', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'Research@iwk.nshealth.ca', 'phone': '902-470-8520'}, {'name': 'Craig Erker', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'IWK Health Centre', 'geoPoint': {'lat': 44.64269, 'lon': -63.57688}}, {'zip': 'L8N 3Z5', 'city': 'Hamilton', 'state': 'Ontario', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '905-521-2100'}, {'name': 'Uma H. Athale', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "McMaster Children's Hospital at Hamilton Health Sciences", 'geoPoint': {'lat': 43.25011, 'lon': -79.84963}}, {'zip': 'M5G 1X8', 'city': 'Toronto', 'state': 'Ontario', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'ask.CRS@sickkids.ca', 'phone': '416-813-7654'}, {'name': 'Pak Yin Anthony Liu', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Hospital for Sick Children', 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}, {'zip': 'H3H 1P3', 'city': 'Montreal', 'state': 'Quebec', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'info@thechildren.com', 'phone': '514-412-4445'}, {'name': 'Stephanie Mourad', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "The Montreal Children's Hospital of the MUHC", 'geoPoint': {'lat': 45.50884, 'lon': -73.58781}}, {'zip': 'H3T 1C5', 'city': 'Montreal', 'state': 'Quebec', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'yvan.samson@umontreal.ca', 'phone': '514-345-4931'}, {'name': 'Monia Marzouki', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Centre Hospitalier Universitaire Sainte-Justine', 'geoPoint': {'lat': 45.50884, 'lon': -73.58781}}, {'zip': 'J1H 5N4', 'city': 'Sherbrooke', 'state': 'Quebec', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'crcinformation.chus@ssss.gouv.qc.ca', 'phone': '819-820-6480'}, {'name': 'Josee Brossard', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Centre Hospitalier Universitaire de Sherbrooke-Fleurimont', 'geoPoint': {'lat': 45.40008, 'lon': -71.89908}}, {'zip': 'G1V 4G2', 'city': 'Québec', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'email': 'rechclinique@crchudequebec.ulaval.ca', 'phone': '418-525-4444'}, {'name': 'Bruno Michon', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "CHU de Quebec-Centre Hospitalier de l'Universite Laval (CHUL)", 'geoPoint': {'lat': 46.81228, 'lon': -71.21454}}, {'zip': '8011', 'city': 'Christchurch', 'status': 'RECRUITING', 'country': 'New Zealand', 'contacts': [{'name': 'Site Public Contact', 'role': 'CONTACT', 'phone': '03 364 0640'}, {'name': 'Andrew J. Dodgshun', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Christchurch Hospital', 'geoPoint': {'lat': -43.53333, 'lon': 172.63333}}], 'overallOfficials': [{'name': 'Shannon M MacDonald', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': "Children's Oncology Group"}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': "Children's Oncology Group", 'class': 'NETWORK'}, 'collaborators': [{'name': 'National Cancer Institute (NCI)', 'class': 'NIH'}], 'responsibleParty': {'type': 'SPONSOR'}}}}